Stockreport

FDA calls for withdrawal of weight loss drug Belviq after trials find cancer link [CNN]

EISAI CO S/ADR  (ESALY) 
NASDAQ:AMEX Investor Relations: eisai.com/ir/index.html
PDF (CNN) incidence of cancer among users Eisai Co., the maker of Belviq, has agreed to withdraw the drug, the FDA said. The FDA announced last month it was reviewing trial [Read more]